Since Set7 can augment Shh activation by increasing Gli3 stability and its DNA binding ability on the promoter regions of Gli1, we then determined whether this Set7-Gli3-Gli1 axis plays a role in tumor development. The gene discussed is GLI1; the disease is neoplasm.